Text

Expansion of Health Savings Account (HSA)-eligible preventive care medicines and services for chronic illnesses 

Date Posted: July 19, 2019

Text

HSA-eligible preventive care benefits expansion for chronic illnesses

The IRS released notice that the list of health savings account (HSA)-eligible preventive care benefits, for those with chronic conditions, has been expanded.

IRS Notice 2019-45, effective July 17, 2019, expands the list of preventive care benefits permitted by a qualifying high-deductible health plan (HDHP) under Section 223 of the Internal Revenue Code. This change, to expand the list of preventive care benefits, applies to plans without a deductible or with a deductible below the applicable minimum deductible for an HDHP.

Here’s what you need to know:

  • These medical services and items are limited to specific medical care services or items listed for the associated chronic conditions specified in Notice 2019-45 (see chart below).
  • IRS explains its criteria – in consultation with HHS – that each listed service or item, when prescribed for an individual with the related chronic condition is low cost and that it has a high likelihood of preventing exacerbation of the chronic condition and/or developing a secondary condition that requires significantly higher cost treatments.

Notice 2019-45 provides that the following services and items for individuals with the specified chronic conditions listed are treated as preventive care:

Preventive Care for Specified Conditions

For Individuals Diagnosed with

Angiotensin Converting Enzyme (ACE) inhibitors

Congestive heart failure, diabetes, and/or coronary artery disease

Anti-resorptive therapy

Osteoporosis and/or osteopenia

Beta-blockers

Congestive heart failure and/or coronary artery disease

Blood pressure monitor

Hypertension

Inhaled corticosteroids

Asthma

Insulin and other glucose lowering agents

Diabetes

Retinopathy screening

Diabetes

Peak flow meter

Asthma

Glucometer

Diabetes

Hemoglobin A1c testing

Diabetes

International Normalized Ratio (INR) testing

Liver disease and/or bleeding disorders

Low-density Lipoprotein (LDL) testing

Heart disease

Selective Serotonin Reuptake Inhibitors (SSRIs)

Depression

Statins

Heart disease and/or diabetes